Vir Biotechnology/ US92764N1028 /
| 2024-05-09 9:59:55 PM | Chg. -0.01 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 9.55USD | -0.10% | 19,379 Turnover: 185,625.35 |
-Bid Size: - | -Ask Size: - | 1.3 bill.USD | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -4.59 USD | -217.99% |
| EPS Diluted: | -4.59 USD | - |
| Revenues per Share: | 0.64 USD | -94.73% |
| Book Value per Share: | 11.78 USD | -24.32% |
| Cash Flow per Share: | -5.77 USD | - |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 86.18 USD | -94.67% |
| Net Income: | -615.06 USD | -219.24% |
| Operating Cash Flow: | -778.79 USD | - |
| Cash and Cash Equivalents: | 241.58 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 14.98 | 15.76 |
| P/BV ratio: | 0.81 | 0.85 |
| P/CF Ratio: | -1.66 | -1.74 |
| PEG: | 0.01 | - |
| Earnings Yield: | -48.01% | -45.63% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 1.3 bill. USD | 1.36 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 135.03 mill. | |
Profitability
| Gross Profit Margin: | 96.79% |
| EBIT Margin: | -794.04% |
| Net Profit Margin: | -713.69% |
| Return on Equity: | -38.68% |
| Return on Assets: | -32.05% |
Financial Strength
| Liquidity I / Cash Ratio: | 137.72% |
| Liquidity II / Quick Ratio: | 137.72% |
| Liquidity III / Current Ratio: | 905.45% |
| Debt / Equity Ratio: | 20.68% |
| Dynam. Debt / Equity Ratio: | -42.22% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
